Pharmaids Pharmaceuticals Q2 Results FY27: Loss Narrows 43.96%, Revenue Rs 4.34 Cr, PAT Rs -1.81 Cr

Pharmaids Pharmaceuticals Ltd (PHARMAID) Q2 Results FY27 announced on 11 November 2026, covering the company's financial performance for the July to September quarter. The results date brought consolidated revenue of Rs 4.34 Cr and a PAT of Rs -1.81 Cr, and the Pharmaids Pharmaceuticals Q2 Results FY27 figures are presented on a consolidated basis, so every number in this article reflects the consolidated results of the group.

The Pharmaids Pharmaceuticals Q2 Results release is covered here through a results analysis of the financial highlights, business drivers, outlook and risks, with the key figures from the BSE filing set out in the Financial Highlights table that follows. Univest tracks the same figures for readers who follow the stock.

Click Here – Get Free Investment Predictions

Pharmaids Pharmaceuticals Q2 Results FY27: Financial Highlights

Metric	Q2 FY27 (Sep 26)	Q2 FY26 (Sep 25)	YoY Change
Revenue	Rs 4.34 Cr	Rs 8.61 Cr	-49.59% YoY
Operating Profit	Rs -1.28 Cr	Rs -6.02 Cr	+78.74% YoY
Net Profit (PAT)	Rs -1.81 Cr	Rs -3.23 Cr	+43.96% YoY

Source: company filing for Pharmaids Pharmaceuticals Q2 Results FY27, 11 November 2026. Figures in Rs Crore, Consolidated basis.

Key Takeaways from Pharmaids Pharmaceuticals Q2 Results: What Stands Out

• Revenue: Consolidated revenue was Rs 4.34 Cr, down 49.59% YoY against Rs 8.61 Cr in the same quarter last year.
• PAT: Net profit was Rs -1.81 Cr against Rs -3.23 Cr, so the net loss improved by 43.96% YoY, a mixed picture for YoY growth.
• Operating Profit: Operating Profit stood at Rs -1.28 Cr compared with Rs -6.02 Cr a year earlier, a 78.74% YoY improvement.
• Sequential view: Pharmaids Pharmaceuticals Q2 Results FY27 also show revenue up 5.3% quarter on quarter from Rs 4.12 Cr, which adds context to the YoY comparison.
• Next: The results analysis that follows explains how revenue, Operating Profit and net profit fit together.

Pharmaids Pharmaceuticals Q2 Results FY27: Performance Analysis

The results analysis shows that Pharmaids Pharmaceuticals reported consolidated revenue of Rs 4.34 Cr, down 49.59% YoY, while net profit was Rs -1.81 Cr against Rs -3.23 Cr a year earlier. Revenue moved lower, but the loss on the profit line was smaller than in the comparison quarter.

In Pharmaids Pharmaceuticals Q2 Results FY27, Operating Profit of Rs -1.28 Cr compares with Rs -6.02 Cr in the year-ago quarter, a 78.74% YoY improvement. The quarterly results therefore show both the Operating Profit loss and the net loss narrowing while revenue is lower, so YoY growth differs by line.

For the Pharmaids Pharmaceuticals Q2 Results, it is worth tracking whether later BSE filings show revenue and net profit moving relative to the year-ago base of Rs 8.61 Cr and Rs -3.23 Cr. The reported figures confirm the numbers but do not establish a specific cause, which is where the business factors come in.

Check the Univest Screener for live results data

Key Business Factors This Quarter

Sequential Revenue – The business factors start with revenue, which was up 5.3% quarter on quarter from Rs 4.12 Cr to Rs 4.34 Cr, and Pharmaids Pharmaceuticals Q2 Results FY27 show this sequential rise alongside the 49.59% YoY decline in consolidated revenue.

Operating Profit – Operating Profit of Rs -1.28 Cr against Rs -6.02 Cr a year earlier shows a 78.74% YoY improvement, and the quarterly results place this beside a net profit of Rs -1.81 Cr against Rs -3.23 Cr.

Return on Capital Employed – Return on capital employed was -15.67% in FY26 compared with -17.65% in FY25, which frames this quarter's figures and leads the results analysis to the FY27 outlook.

FY27 Outlook After Pharmaids Pharmaceuticals Q2 Results

The FY27 outlook is tied to the quarters still to be reported. Full-year results for Pharmaids Pharmaceuticals will depend on how revenue and net profit develop in the third and fourth quarters, and this results analysis relies only on the reported figures.

On the reported numbers, Pharmaids Pharmaceuticals Q2 Results FY27 give a base of Rs 4.34 Cr of revenue and Rs -1.81 Cr of net profit for the quarter. Net profit in the coming quarters, read against these figures on the Univest Screener, will show how the year builds, which leads to the risks.

Key Risks to Watch After Pharmaids Pharmaceuticals Q2 Results FY27

Revenue Decline

Revenue declined 49.6% year on year to Rs 4.34 Cr in the latest quarter, and Pharmaids Pharmaceuticals Q2 Results FY27 show this on the consolidated basis, so YoY growth in revenue is the first item to watch in later disclosures.

Net Loss and Margin

The company reported a net loss of Rs 1.81 Cr in the latest quarter, and the net profit margin was -41.7% against -37.5% in the comparison quarter, which makes the next consolidated results the reference point.

Return on Equity

Return on equity was low at -21.64% in FY26, so one quarter's figure should be read alongside the full-year ratio and the other numbers in the quarterly results.

Download the Univest iOS App or Univest Android App to track quarterly results as they are declared.

Conclusion

The quarterly results show Pharmaids Pharmaceuticals Q2 Results FY27 with consolidated revenue of Rs 4.34 Cr and net profit of Rs -1.81 Cr, against Rs 8.61 Cr and Rs -3.23 Cr a year ago. The consolidated results point to a quarter where revenue fell 49.59% and the net loss improved by 43.96%, as detailed in the sections above. Readers who follow Pharmaids Pharmaceuticals Q2 Results should consult a SEBI-registered advisor before acting on any of these figures.

Frequently Asked Questions on Pharmaids Pharmaceuticals Q2 Results FY27

What are Pharmaids Pharmaceuticals Q2 Results FY27?

Ans. Pharmaids Pharmaceuticals Q2 Results FY27 report consolidated revenue of Rs 4.34 Cr and net profit of Rs -1.81 Cr for July to September 2026, so revenue is lower while the loss is smaller, as the Financial Highlights table shows.

What is the results date for Pharmaids Pharmaceuticals Q2 Results FY27?

Ans. The results date for Pharmaids Pharmaceuticals Q2 Results FY27 is 11 November 2026, which means the quarterly results cover July to September 2026 and are summarised in the opening paragraphs of this article.

What revenue was reported in Pharmaids Pharmaceuticals Q2 Results FY27?

Ans. Pharmaids Pharmaceuticals reported consolidated revenue of Rs 4.34 Cr in the quarter, compared with Rs 8.61 Cr a year earlier, which means revenue is down 49.59% YoY, as the Performance Analysis section explains.

What net profit was reported in Pharmaids Pharmaceuticals Q2 Results FY27?

Ans. Net profit in Pharmaids Pharmaceuticals Q2 Results FY27 was Rs -1.81 Cr, against Rs -3.23 Cr in the year-ago quarter, while the Key Takeaways section places this as a 43.96% improvement in the net loss.

How much YoY growth did revenue show in Pharmaids Pharmaceuticals Q2 Results FY27?

Ans. Revenue showed a YoY decline of 49.59% in Pharmaids Pharmaceuticals Q2 Results FY27, moving from Rs 8.61 Cr to Rs 4.34 Cr, while the net loss narrowed alongside it, as the Performance Analysis section details.

Did net profit rise or fall in Pharmaids Pharmaceuticals Q2 Results?

Ans. Net profit improved in Pharmaids Pharmaceuticals Q2 Results as the loss narrowed from Rs -3.23 Cr to Rs -1.81 Cr, a 43.96% YoY change, while revenue declined 49.59%, as covered under Key Takeaways.

What was the Operating Profit in Pharmaids Pharmaceuticals Q2 Results FY27?

Ans. Operating Profit in Pharmaids Pharmaceuticals Q2 Results FY27 was Rs -1.28 Cr, against Rs -6.02 Cr a year earlier, which means a 78.74% YoY improvement, as the Performance Analysis section explains.

Are Pharmaids Pharmaceuticals Q2 Results consolidated results or standalone results?

Ans. Pharmaids Pharmaceuticals Q2 Results are consolidated results, with revenue of Rs 4.34 Cr and net profit of Rs -1.81 Cr, so every figure follows the consolidated basis noted in the Quick Answer.

What business factors shaped Pharmaids Pharmaceuticals Q2 Results FY27?

Ans. Business factors in Pharmaids Pharmaceuticals Q2 Results FY27 include revenue up 5.3% quarter on quarter from Rs 4.12 Cr and an Operating Profit of Rs -1.28 Cr, which are set out in Key Business Factors This Quarter.

What are the key risks after Pharmaids Pharmaceuticals Q2 Results FY27?

Ans. Key risks after Pharmaids Pharmaceuticals Q2 Results FY27 are the 49.6% YoY revenue decline, a net loss of Rs 1.81 Cr and return on equity of -21.64% in FY26, which the Key Risks to Watch section lists in order.

What is the outlook after Pharmaids Pharmaceuticals Q2 Results?

Ans. The outlook after Pharmaids Pharmaceuticals Q2 Results rests on the quarters still to be reported in FY27, so full-year results depend on later revenue and net profit, as the FY27 Outlook section explains.

Where can I find the complete Pharmaids Pharmaceuticals Q2 Results FY27 data?

Ans. The complete Pharmaids Pharmaceuticals Q2 Results FY27 data is on BSE under scrip ID PHARMAID, while the Financial Highlights table and the Univest Screener summarise revenue and net profit for this quarter.